Kimtech cleanroom coveralls launched
Kimberly-Clark Professional has launched Kimtech Pure A5 cleanroom coveralls, for sterile and non-sterile environments, to provide an affordable way to reduce the risk of contamination.
Encorium terminates sale plans on success of vaccines strategy
Encorium has abandoned plans to sell its Finnish unit, Encorium OY, citing its new strategic focus and recent contract wins as the basis for the decision.
The FDA has warned consumers about the spread of counterfeit H1N1 treatments after the agency bought products advertised as Tamiflu (oseltamivir) that contained none of the active ingredient.
APC’s new R&D unit to focus on complex peptides
The American Peptide Company (APC) plans to set up an R&D unit at its facility in Sunnydale, California to better serve growing demand for innovative technologies.
Pharma not concerned enough about environment when outsourcing; CEO
Environmental and safety matters concern pharma “less than they should” when outsourcing to Asia, according to the CEO of Ash Stevens who believes there are long term benefits of using US-based companies.
Medpace lands Ph III AMR101 trial contract
US specialist cardiovascular CRO Medpace will run Phase III trials of Amarin’s candidate triglyceride drug, AMR101.
Prof Kummerer wins Recipharm environmental award
Swedish CDMO Recipharm’s International Environmental Award helps emphasize the drug industry’s wider role in society, according to company chairman Lars Backsell.
Lonza withdraws Patheon bid, but still keen on CMOs
Swiss healthcare services giant Lonza has withdrawn its offer for Canadian CMO Patheon, citing value considerations, rejection of the bid by JLL and the availability of alternatives.
H Lundbeck eschews outsourcing and buys Elaiapharm
CNS focused drugmaker H Lundbeck says its acquisition of French CMO Elaiapharm represents a cheaper option than third-party manufacturing.
Appointments at Peregrine Pharmaceuticals, Seaside Therapeutics and Eucodis – People on the move
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Peregrine Pharmaceuticals, Seaside Therapeutics and Eucodis.
Valois discusses what patients want from a device
Patients want nasal delivery devices that are portable, hygienic and can be used discretely, according to a director at Valois who delivered a talk on the company’s side-actuated product at CPhI 2009.
CRO Biomodels makes preclinical osteoarthritis breakthrough
US CRO Biomodels says preclinical research on lubricin suggests the recombinant human protein could form the basis of a new osteoarthritis (OA) treatment.
Animal testing could be eliminated; Kirkstall
A spectrum of systems could eventually replace animal testing and provide a more ethical and economical route through preclinical, according to Kate Darley, business development manager at Kirkstall.
Siro adds trial supply capacity in India
Indian CRO Siro Clinpharma has ramped up clinical trial manufacturing capacity at its facility in Mumbai in response to growing demand from pharma and biotech firms.
ChemDiv’s Russian arm wins Viriom HIV research contract
ChemDiv’s subsidiary Chemical Diversity Research Institute (CDRI), based in Moscow, Russia, will carry out development work on a range of HIV antivirals on behalf of new drugmaker Viriom.